Updated Date:
16 Nov 2026
Product Detail:
RYALTRIS olopatadine 600 microgram/actuation and mometasone furoate 25 microgram/actuation nasal spray bottle
Shortage Status:
Anticipated
AUST R:
473905
Availability:
Available
Active Ingredient:
olopatadine hydrochloride~mometasone furoate monohydrate
Reason:
Unexpected increase in consumer demand
Dosage Form:
Spray,nasal
Supply Impact Dates
From 30 Nov 2026
To 04 Jan 2027
Management Action:
The sponsor is working to expedite the next shipment. Alternative presentation is available.